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Two regions containing tandemly repeated sequences are present in the fowl adenovirus 9 (FAdV-9) genome. The longer
repeat region (TR-2) is composed of 13 contiguous 135-bp-long direct repeats, the function of which is unknown. An infectious
FAdV-9 genomic clone, constructed by homologous recombination in Escherichia coli, was used for engineering of recom-
binant viruses. The enhanced green fluorescence protein (EGFP) coding sequence was cloned in both rightward and leftward
orientations so as to replace TR-2. Replication-competent recombinant FAdVs were recovered, demonstrating that TR-2 was
dispensable for FAdV-9 propagation in vitro. The expression of EGFP in infected cells was demonstrated by fluorescence
microscopy, immunoprecipitation, and RT-PCR. © 2001 Academic Press
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The family Adenoviridae includes viruses that have
been isolated from many mammalian (genus Mastade-
novirus) and avian (genus Aviadenovirus) species. Avian
denoviruses (AAdVs) are further subdivided into three
erological groups (McFerran, 1997). Fowl adenoviruses
FAdV 1–12) belong to group I AAdVs and share a com-
on group antigen with viruses isolated from geese,
ucks, and turkeys. Several features distinguish FAdVs
rom their mammalian counterparts. Two fibers protrud-
ng from the penton base were observed when 14 FAdV
trains, representing 11 serotypes, were examined by
lectron microscopy (Gelderblom and Maichle-Lauppe,
982), whereas almost all mastadenoviruses, with the
xception of subgroup F human adenoviruses (HAdVs),
ave only one fiber per penton base (Kidd et al., 1993;
eh et al., 1994). FAdV genomes are much larger than
hose of other adenoviruses (AdVs), and FAdV-9 has the
ongest AdV genome whose complete nucleotide se-
uence has been determined so far, 45,063 bp. More-
ver, FAdV-1 (CELO virus) and FAdV-9 do not have rec-
gnizable early regions 1, 3, and 4, and although most
ate genes are well conserved, protein V coding se-
uences could also not be identified (Chiocca et al.,
996; Ojkic and Nagy, 2000). Certain FAdV genes have
ery specialized functions and one of these facilitated
he evaluation of an important aspect of the AdV repli-
ation cycle. The importance of heat-shock response to
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Pathobiology, Ontario Veterinary College,
niversity of Guelph, Guelph, Ontario, N1G 2W1, Canada. Fax: 519-824–1930. E-mail: enagy@ovc.uoguelph.ca.
197dV replication in mammalian AdV-infected cells could
ot be determined because mammalian AdV genes im-
licated in the process have a role in other essential
teps of virus replication. However, it was possible to
emonstrate that the induction of a heat-shock response
n FAdV-infected cells is an essential step in AdV repli-
ation since CELO virus utilizes a single gene, Gam1, to
nduce the heat-shock response in infected cells (Glotzer
t al., 2000).
Early regions 1, 3, and 4 are the common sites to
ccommodate foreign genes in recombinant mammalian
dVs. Since FAdVs lack these regions, alternative strat-
gies had to be explored for the construction of FAdV-
ased vectors. Mutational analysis demonstrated that
ELO virus could tolerate deletions/insertions into the
ight end of its genome, which allowed the generation of
eplication-competent recombinant viruses (Michou et
l., 1999). However, deletions in the right end of FAdV
enomes can have a negative impact on virus growth,
nd depending on the location and the extent of dele-
ions, these may result in a severe drop in titers of
ecombinant viruses (Johnson et al., 2000). The left end of
he CELO virus genome contains regions that could be
eleted and supplied in trans, but since no complement-
ng cell lines are available to support propagation of
eplication-defective FAdVs, only replication-competent
ecombinant FAdVs have been characterized in more
etail.
An unusual feature of the FAdV-9 genome is the
resence of two regions of tandemly repeated se-
uences (Cao et al., 1998). Imperfect repeats found in
he early region 4 of mouse adenovirus type 1 appear
o have an impact on virus pathogenicity (Ball et al.,
991). Tandem reiterations have also been described
0042-6822/01 $35.00
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198 OJKIC AND NAGYin DNA from canine adenovirus 1 vaccine strain CLL
(Sira et al., 1987) and a mutant human adenovirus 34
Chen and Horwitz, 1990) as part of the inverted ter-
inal repeats. On the other hand, FAdV-9 tandem
epeats are located on the right end of the viral ge-
ome and are incorporated within a region rich in
FIG. 1. (A) The strategy for construction of pPacFAdV9. FAdV-9 term
fragment from pF-ApaI into SmaI-digested pWE-PacITR so that it now
enerating pFAP2. Plasmid pFAP2 was then linearized with ApaI a
generating pPacFAdV9. Thick black lines represent FAdV-9 sequenc
represent vector sequences. (B) The strategy for construction of
generated by inserting the EGFP-coding sequence (excised from pE
paI–XbaI fragment in pFDSal was replaced with ApaI–XbaI fragmen
ontaining modified viral genomes (pFDTR2-EGFP and pFDTR2-EG
GFPinv, pFDSal-EGFP, and FAdV-9 DNA. Thick black lines represen
ther gray shaded lines represent vector sequences. (C) Tandem rep
ach subunit has two Eco52I recognition sites. TR-2 was deleted by
f deleted TR-2. The recombinant virus containing EGFP sequen
ecombinant virus containing the EGFP sequence in rightward oriepen reading frames. The shorter repeat region (TR-1) is composed of five 33-bp-long direct repeats located
etween nt 37,648 and 37,812, whereas the longer
epeat region (TR-2), positioned between nt 38,807 and
0,561, contains 13 tandemly repeated 135-bp-long
ubunits (Ojkic and Nagy, 2000). Interestingly, se-
uences similar to FAdV-9 TR-2 were detected in field
agments in pWE-PacITR were extended by inserting the SmaI–SmaI
ns the complete ApaI left 4.9-kb and right 6.7-kb terminal fragments,
ransformed into competent BJ5183 E. coli along with FAdV-9 DNA,
hatched blocks represent TR-2. Thin and other gray shaded lines
2-EGFP and pFDTR2-EGFPinv. pAC-EGFP and pAC-EGFPinv were
1 with Bsp120I and NotI) into Eco52I-digested pAC8, deleting TR-2.
pAC-EGFP and pAC-EGFPinv, respectively. Recombinant plasmids
were generated by recombination between SalI-linearized pFDSal-
9 sequences and the hatched blocks are TR-2 sequences. Thin and
ion as EGFP insertion site. TR-2 contains 13 repeated subunits and
on with Eco52I, and EGFP coding sequences were inserted in place
leftward orientation was designated rFDTR2-EGFP, whereas the
was designated rFDTR2-EGFPinv.inal fr
contai
nd cot
es and
pFDTR
GFP-N
ts from
FPinv)
t FAdV-
eat reg
digesti
ce in
ntationsolates of fowl adenoviruses from Ontario, India (unpub-
fT
—Cont
199TR-2 IS NOT REQUIRED FOR FAdV REPLICATIONlished data), and Australia (Johnson et al., 2000), but the
unction(s) of these repeats, if any, is unknown.
The objectives of this study were to determine whether
R-2 was dispensable for FAdV-9 propagation in vitro
and to examine the suitability of TR-2 as a site for
FIG. 1insertion of foreign genes. We inserted the enhancedgreen fluorescence protein (EGFP) coding sequences in
both rightward and leftward orientations as marker gene
in place of the deleted TR-2, developed a system for the
construction of TR-2-deleted recombinant FAdVs, gener-
ated recombinant FAdVs, and examined their potential
inuedas gene expression vectors in vitro.
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200 OJKIC AND NAGYRESULTS
onstruction of recombinant FAdV-9 viruses
The construction of a plasmid containing the entire
AdV-9 genome was central to the overall strategy since
eneration and rescue of recombinant FAdV-9 viruses
epended on a full-length, infectious genomic clone of
he viral DNA. The construction of the FAdV-9 genomic
lone, designated pPacFAdV9, was carried out in a se-
ies of cloning steps coupled with recombination be-
ween a plasmid containing cloned FAdV-9 end frag-
ents (pFAP2) and FAdV-9 DNA in Escherichia coli, as
epicted in Fig. 1A. When the PacI-digested pPacFAdV9
NA was transfected into CH-SAH cells, infectious vi-
uses were recovered.
A three-step cloning/recombination approach (see Ma-
erials and Methods for detailed explanations) was utilized
o construct recombinant plasmids containing modified vi-
al genomes. The EGFP coding sequence was inserted in
ightward (pFDTR2-EGFPinv) and leftward (pFDTR2-EGFP)
rientations in place of deleted TR-2, as shown in Figs. 1B
nd 1C. A cytopathic effect was observed between 5 and 7
ays after transfections of CH-SAH cells with PacI-digested
FDTR2-EGFPinv and pFDTR2-EGFP DNA. The recombi-
ant virus generated after transfection with the former was
esignated rFDTR2-EGFPinv, whereas the virus generated
after transfection with the latter was designated rFDTR2-
EGFP.
The DNA extracted from rFDTR2-EGFP and rFDTR2-
EGFPinv were digested with BamHI and separated by
agarose gel electrophoresis. The estimated sizes of
BamHI fragments concurred with those predicted by
computer sequence analysis of FAdV-9 DNA (Fig. 2). The
presence of EGFP coding sequences in DNA extracted
FIG. 2. Restriction enzyme digestion and Southern blot analysis of
ecombinant viruses and FAdV-9. (A) BamHI digestion of DNA extracted
from FAdV-9 (lanes 1), rFDTR2-EGFP (lanes 2), and rFDTR2-EGFPinv
(lanes 3). Lanes 4: 1-kb ladder. (B) DNA from the gel shown in A was
transferred onto a Nytran membrane and probed with a DIG-labeled
EGFP probe.from recombinant viruses was also confirmed by South-ern blot analysis with an EGFP probe. The difference in
sizes of BamHI DNA fragments that contained EGFP
sequences (1.4 kb in rFDTR2-EGFP; 1.8 kb in rFDTR2-
EGFPinv) is due to different orientations of the EGFP
coding sequences (Fig. 1C). The integrity of the junctions
between viral sequences and cloned EGFP DNA was
also confirmed by sequencing of the 1.5-kb ApaI/XbaI
fragments obtained from recombinant viruses.
To examine the stability of the modified viral genomes,
recombinant viruses were plaque-purified through four
passages in cultured cells. DNA was extracted from 12
plaque-purified recombinant viruses and subjected to
restriction enzyme analysis. No detectable differences in
the restriction enzyme pattern were observed between
DNA extracted from recombinant viruses representing
the first and fourth passages. The plaque morphology of
the rFDTR2-EGFP and rFDTR2-EGFPinv was also indis-
tinguishable from that of FAdV-9 (data not shown).
Analysis of EGFP expression
Fluorescence microscopy was utilized for rapid detec-
tion of EGFP expression in CH-SAH and QT-35 cells that
were infected with recombinant viruses. Green fluores-
cence was observed in cells infected with both rFDTR2-
EGFP and rFDTR2-EGFPinv. However, rFDTR2-EGFPinv
induced much higher levels of EGFP expression than
rFDTR2-EGFP, as judged by the intensity of green fluo-
rescence in infected cells (Fig. 3), and was used in all
subsequent experiments.
EGFP expression in rFDTR2-EGFPinv-infected CH-
SAH cells was also evaluated by immunoprecipitation.
CH-SAH cells were labeled with [35S]methionine at vari-
FIG. 3. Detection of EGFP expression 24 h.p.i. by fluorescence
microscopy in cells infected at an m.o.i. of 1. (A) CH-SAH cells infected
with FAdV-9. (B) rFDTR2-EGFP-infected CH-SAH cells. (C) rFDTR2-
EGFPinv-infected CH-SAH cells. (D) rFDTR2-EGFPinv-infected QT-35
cells.
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201TR-2 IS NOT REQUIRED FOR FAdV REPLICATIONous times postinfection (p.i.). Proteins from lysates of
radiolabeled cells were immunoprecipitated with an
EGFP-specific monoclonal antibody, separated by SDS–
PAGE, and visualized by fluorography. A major band at a
molecular mass of 27 kDa was observed in cells infected
with rFDTR2-EGFPinv, but not in mock-infected or FAdV-
9-infected CH-SAH cells and was in agreement with the
expected molecular mass of EGFP, 27 kDa (Fig. 4). EGFP
expression in infected cells could be detected by fluo-
rescence microscopy and immunoprecipitation only dur-
ing the late times of rFDTR2-EGFPinv infection.
One-step growth curve
Importantly, the one-step growth curve experiment re-
sults indicated that rFDTR2-EGFPinv grew as efficiently
as FAdV-9 (Fig. 5). The kinetics of rFDTR2-EGFPinv rep-
FIG. 4. Detection of EGFP by immunoprecipitation. CH-SAH cells
were either mock-infected (lane 1) or infected with rFDTR2-EGFPinv
(lanes 2, 3, and 5) or FAdV-9 (lane 4) and labeled with [35S]methionine.
ell lysates were obtained from infected cells at different times p.i.
lanes 1 and 2: 18 h; lane 3: 24 h; lanes 4 and 5: 36 h) and immuno-
recipitated with an EFGP-specific monoclonal antibody. Immunopre-
ipitated proteins were separated by SDS–PAGE and visualized by
luorography. Lane M: marker.
FIG. 5. One-step growth curves for rFDTR2-EGFPinv and FAdV-9. C
rFDTR2-EGFPinv and FAdV-9 at an m.o.i. of 5. Supernatants and cells
monitored by plaque assays. The data represents two replicates at each timlication in cultured cells was lower than that of its wild-
type counterpart between 12 and 30 h.p.i. However, be-
tween 36 and 48 h.p.i., rFDTR2-EGFPinv titers were sim-
ilar to those obtained for FAdV-9.
The yield of recombinant virus was routinely 1–2 3 108
plaque-forming units/ml (p.f.u./ml), which is similar to
titers normally obtained for FAdV-9 (3 3 108 p.f.u./ml).
Temporal analysis of EGFP mRNA expression
The temporal transcription profile of EGFP mRNA in
rFDTR2-EGFPinv-infected cells was examined by RT-PCR
at various times p.i. Although both fluorescence micros-
copy and immunoprecipitation results suggested that
EGFP expression occurred during the late phase of in-
fection, mRNA transcription may have started earlier. A
low level of EGFP mRNA was detected as early as 2 h.p.i.
but then decreased to barely detectable levels between
4 and 10 h.p.i. The level of EGFP mRNA expression
increased detectably between 10 and 12 h.p.i. and con-
tinued throughout the late phase of infection (Fig. 6).
Identification of FAdV-9 leader sequences, promoters,
and poly(A) site
59-RACE analysis was carried out with EGFP-specific
primers to examine the structure of EGFP mRNA 24 h.p.i.
and to eventually identify the promoter used to initiate
EGFP expression in cells infected with rFDTR2-EGFPinv.
Sequence analysis of the 59-RACE product of the un-
translated 59 portion of EGFP mRNA revealed the pres-
ence of bipartite leader sequences, which were also
found in the untranslated 59 regions of CELO virus late
ranscripts (Payet et al., 1998). The first leader was lo-
ated between nt 8385 and 8414 and the second leader
t monolayers of CH-SAH cells in six-well dishes were infected with
harvested at various times p.i. and the production of total virus wasonfluen
weree point.
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202 OJKIC AND NAGYwas between nt 12,299 and 12,421. Following the bipartite
leader the first nucleotide upstream of the EGFP was at
nt 38,503, 287 nts from the EGFP ATG initiation codon.
The presence of these leader sequences on the EGFP
mRNA suggested that EGFP was expressed from the
major late promoter (MLP). The location of FAdV-9 MLP
was predicted between nt 8173 and 8361, with a putative
TATA box located between nt 8345 and 8351 (Ojkic and
agy, 2000). 39-RACE with EGFP-specific primers was
lso carried out and the nucleotide sequence of the
loned 39-RACE product was analyzed. The EGFP mRNA
as polyadenylated and the terminal end was at nt
0,178. This suggests that the polyadenylation signal
sed for EGFP mRNA was the one located between nt
0,155 and 40,159 (Fig. 7).
DISCUSSION
Our results demonstrated that TR-2 was dispensable
or in vitro virus replication since deletion of TR-2 and
insertion of the EGFP coding sequence in either orien-
tation did not have a significant impact on FAdV-9 growth
characteristics. In contrast to HAdV vectors where ex-
pression cassettes containing exogenous promoters and
polyadenylation sites are often used, the EGFP gene
inserted in place of TR-2 lacked additional transcriptional
elements. Nevertheless, EGFP expression was under the
control of the endogenous FAdV-9 MLP. Moreover, late in
infection, high levels of transgene expression were de-
FIG. 6. Kinetics of EGFP mRNA expression in rFDTR2-EGFPinv in-
fected cells. CH-SAH cells were either mock-infected (lane N) or in-
fected with rFDTR2-EGFPinv or FAdV-9. Total RNA was extracted at
various times p.i., indicated by the numbers above the lanes, reverse
transcribed, and amplified by PCR with primers internal to EGFP mRNA.
PCR products were separated by agarose gel electrophoresis and
visualized by ethidium bromide staining. Lane M: 1-kb ladder.
FIG. 7. The structure of EGFP mRNA in cells infected with rFDTR2-
reverse transcribed and used for 59- and 39-RACE. The sequence analysis oftected by RT-PCR, fluorescence microscopy, and radio-
immunoprecipitation.
The role of TR-2, if any, during the natural course of
FAdV-9 infection is unknown. The hypervirulent FAdV-8
strain CFA40 genome has seven 145-bp-long tandem
repeats, showing 80.4% similarity to FAdV-9 TR-2 and in
a similar location as in FAdV-9. Although the develop-
ment of FAdV-8 strain CFA40-based vectors has been
reported, the role of these sequences was not investi-
gated (Johnson et al., 2000). Interestingly, in our labora-
ory Southern hybridization revealed sequences similar
o FAdV-9 TR-2 in numerous FAdV field isolates associ-
ted with outbreaks of inclusion body hepatitis in chick-
ns in Ontario. Partial DNA sequence analysis of two
ield isolates demonstrated that, although other parts of
he genomes of these viruses showed relatively weak
imilarities to FAdV-9, they also contained repeats with
8% identity to FAdV-9 TR-2. Furthermore, the DNA ob-
ained from an FAdV field isolate from India contained
equences which were identical to FAdV-9 TR-2 (data not
hown). The presence of TR-2-like sequences in FAdV
ield isolates originating from three continents suggests
hat TR-2-related sequences might play an important role
uring the natural course of infection. Since several
ifferent FAdV serotypes have been associated with in-
lusion body hepatitis, the genotype might play a more
mportant role than the serotype in the pathogenicity of
he particular group I AAdV strain (McFerran, 1997). In-
erted and direct repeat sequences, playing various
oles in viral replication cycles, have also been found in
etroviruses, poxviruses, and herpesviruses. In most
ases, the exact role of tandem repeats is still elusive
nd their overall implications and precise role in virus
eplication are not well understood. However, it has been
eported that tandemly repeated sequences could be
nvolved in modulation of viral virulence and oncogenic-
ty. For example, Marek’s disease virus (MDV) contains a
ariable number of copies of a 132-bp-long direct repeat.
n increase in the copy number of this repeat has been
ositively correlated with viral attenuation, but it is not
he only determinant of MDV virulence (Tulman et al.,
000). The sequence similarity between FAdV-9 TR-2 and
he MDV 132-bp repeat is relatively low, only 35.9% at the
v. Total RNA extracted from cells infected with rFDTR2-EGFPinv wasEGFPin
cloned cDNAs revealed the presence of bipartite leaders.
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203TR-2 IS NOT REQUIRED FOR FAdV REPLICATIONnucleotide level, and these repeats do not appear to be
related. However, a possible role of TR-2 as a genotype-
associated factor which might be involved in modulating
FAdV virulence is intriguing and future studies are re-
quired to examine the role of TR-2 in vivo.
Since TR-2 is dispensable, it can be used as an alter-
native site for insertions of foreign genes. The develop-
ment of transfer plasmids in which TR-2 is replaced with
a gene of interest, and our strategy to generate a recom-
binant virus in two cloning steps followed by recombina-
tion in E. coli, simplifies the time-consuming and labor-
intensive process of production and purification of re-
combinant viruses. These FAdV-9 vectors will be
developed as recombinant vaccines for poultry, where
use of replication-competent viruses could be advanta-
geous in inducing a protective immune response. Well-
characterized HAdVs have been extensively used in re-
combinant vector development for both humans and an-
imals. Nonetheless, we note that FAdV-9-based vectors
have several characteristics that could make them even
more attractive for applications in mammalian species.
The genome of FAdVs is much larger (;45 kb) than
genomes from mammalian AdVs (;30–36 kb). This prop-
erty might allow for insertion of larger genes into FAdV-
based vectors compared to HAdV-based vectors. While
the presence of HAdV neutralizing antibodies can se-
verely limit their usefulness for human applications, it is
less likely that a preexisting immune response to FAdVs
exists. HAdV infections are common in humans, so that
even helper-dependent HAdV vectors might revert to
replication-competent viruses by in vivo recombination
with naturally occurring HAdVs. FAdVs are naturally rep-
lication-defective in human cells, which provides an ad-
ditional safety feature (Cotten et al., 1993). However, they
an still be used for gene delivery and expression in
onpermissive mammalian systems. For example, CELO
irus is capable of transducing several types of human
ells in culture at levels comparable to HAdV-5 (Michou
t al., 1999).
We have found that rFDTR2-EGFPinv could also trans-
uce human lung carcinoma cells (A549) and bovine
idney (MDBK) cells (data not shown). However, trans-
uction efficiency (judged by the number of infected cells
xpressing EGFP) and EGFP expression levels in the
ammalian cells (judged by the intensity of green fluo-
escence in transduced cells) were lower than those
bserved in cells of avian origin, even though the cells
ere infected with the same m.o.i. It is clear that more
etailed characterization of FAdV molecular biology and
valuation of viral gene expression are required before
AdV vectors could be used in nonpermissive systems.
he work reported here lays the foundation for further
tructural and functional studies of FAdV-9 and facilitates
ur efforts in developing this virus as a recombinant
ector.MATERIALS AND METHODS
irus
FAdV-9 was obtained from ATCC as avian adenovirus
ype 8, strain A-2A (ATCC VR-833). In the older North
merican literature this strain is often called avian ade-
ovirus type 8, but in the more recent North American
iterature the same strain is called fowl adenovirus type
and fowl adenovirus serotype 9. In the older European
iterature the strain A2 is called fowl adenovirus serotype
, whereas in the newer European literature the same
train is sometimes designated serotype 10. In our pre-
ious publications (Clavijo et al., 1996; Alexander et al.,
1998; Cao et al., 1998, 2000; Ojkic and Nagy, 2000) the
strain A-2A is called avian/fowl adenovirus type 8. How-
ever, in the Seventh Report of the International Commit-
tee on Taxonomy of Viruses (Benko¨ et al., 2000) strain
-2A is now listed as FAdV-9 and therefore in this paper
e followed the official designation.
ell lines
The virus was propagated in a chicken hepatoma cell
ine (CH-SAH), kindly provided by Solway Animal Health
Mendota Heights, MN). Quail tumor cells (QT-35) were a
enerous gift from C. Moscovici. The cells were main-
ained in DMEM-F12 medium (Life Technologies) supple-
ented with 10% fetal bovine serum (FBS; Cansera), 2
M L-glutamine, 100 U/ml penicillin, and 100 mg/ml
streptomycin.
Viral DNA extraction
The viral DNA was extracted from purified virus. In-
fected cells were harvested at maximum CPE, freeze-
thawed 3 times, and centrifuged at 6000 rpm in a Beck-
man 16.250 rotor for 30 min at 4°C to remove cellular
debris. The virus was pelleted by ultracentrifugation and
resuspended in TE buffer (pH 8.0). The 30-ml centrifuge
tube was filled to 2/3 of its volume with the virus sus-
pension, and 1/3 of the volume of ice-cold sucrose so-
lution (30% w/w in TE buffer) was then layered beneath
the virus suspension. The tube was centrifuged at 24,000
rpm in a Beckman SW-28 rotor for 90 min at 4°C; the
supernatant was removed and the pellet was resus-
pended in 1 ml TE buffer. The virus was disrupted by
addition of an equal volume of 23 lysis buffer [0.01 M
Tris–HCl (pH 7.5) 0.01 M EDTA, 1% SDS, 1 mg/ml protein-
ase K in 0.01 M Tris–HCl (pH 8)] and incubated overnight
at 37°C. The lysed virus was then extracted with phenol,
the aqueous phase was transferred to a fresh centrifuge
tube, and viral DNA was recovered by ethanol precipita-
tion.
Construction of FAdV-9 genomic clones
The strategy for the construction of a full-length FAdV-9
genomic plasmid clone is depicted in Fig. 1A. A plasmid
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204 OJKIC AND NAGY(pITR) containing the FAdV-9 left 2.5-kb and right 1.5-kb
SmaI-terminal fragments in opposite orientation was ini-
tially constructed. The terminal fragments, contained in a
BamHI fragment, were then transferred into pWE-Amp, a
modified cosmid vector derived from pWE-15 (Clontech)
and PacI-restriction sites were introduced into the ends
of the cloned viral DNA by linker addition (pWE-PacITR).
AdV-9 DNA lacks PacI sites and PacI sites were intro-
duced to enable linearization of cloned viral DNA from
the plasmid prior to transfections. The FAdV-9 terminal
fragments in pWE-PacITR were then extended by insert-
ng the SmaI–SmaI fragment from pF-ApaI so that it now
ontains the complete ApaI left 4.9-kb and right 6.7-kb
erminal fragments (pFAP2). Recombination in E. coli was
carried out as first described by Chartier et al. (1996).
pFAP2 was linearized with ApaI and cotransformed into
competent BJ5183 E. coli (kindly provided by D. Hanahan)
long with FAdV-9 DNA, allowing for recombination be-
ween overlapping fragments to occur and generating
PacFAdV9, a plasmid containing the entire cloned
AdV-9 genome. Restriction enzyme analysis verified the
orrect structure of the plasmid.
eneration of recombinant FAdV-9 viruses
A three-step strategy was developed for the construc-
ion of two recombinant viruses. Plasmid pAC-Not(2)
ontains ApaI FAdV-9 terminal fragment between nt
8,288 and 45,063, including the TR-2. In the first step the
GFP coding sequence was excised from pEGFP-N1
Clontech) with Bsp120I and NotI and cloned into Eco52I-
digested pAC8 (see Fig. 1A) in both rightward (pAC-
EGFPinv) and leftward (pAC-EGFP) orientations, deleting
TR-2. In the second step the ApaI–XbaI fragments (con-
taining the EGFP coding sequence in place of the de-
leted TR-2) were excised from pAC-EGFP and pAC-EGF-
Pinv and used to replace the ApaI–XbaI fragment in the
plasmid pFDSal (constructed by digesting pPacFAdV9
with SalI to completion followed by religation resulting in
deletion of all internal SalI fragments from pPacFAdV9).
Two transfer vectors were constructed, containing the
EGFP coding sequence in rightward (pFDSal-EGFPinv)
and leftward (pFDSal-EGFP) orientations. In the third
step, the transfer vectors pFDSal-EGFPinv and pFDSal-
EGFP were linearized with SalI and cotransformed into
competent BJ5183 E. coli along with FAdV-9 DNA. Result-
ant recombinant plasmids contained modified viral ge-
nomes with EGFP coding sequences replacing deleted
TR-2 in rightward (pFDTR2-EGFPinv) and leftward
(pFDTR2-EGFP) orientations (Fig. 1B). Restriction enzyme
analysis verified the correct structure of the cloned viral
DNAs.
Transfections
PacI-digested cloned viral DNAs (pPacFAdV9,
pFDTR2-EGFP, and pFDTR2-EGFPinv) were transfectedinto CH-SAH cells by Lipofectamin (Life Technologies) as
suggested by the manufacturer. Approximately 1 mg of
DNA and 5 ml of Lipofectamin were used for each trans-
fection. Cells were exposed to the DNA–liposome com-
plexes overnight and 1 ml of DMEM-F12 containing 20%
FBS was added the next morning. The medium was
replaced with fresh, complete DMEM-F12 24 h after
transfection. CPE was typically observed between 5 and
7 days after transfections.
Southern blotting
Viral DNA extracted from purified virions was digested
with restriction enzymes and separated by agarose gel
electrophoresis. Transfer of DNA from agarose gels to
nylon membranes (Schleicher and Schuell) was carried
out as described elsewhere (Southern, 1975). DIG DNA
Labeling and Detection Kit (Roche) was used for the
labeling of gel-purified EGFP DNA (BamHI–NotI fragment
from pEGFP-N1). The manufacturer’s instructions were
followed for the hybridization of DIG-labeled EGFP probe
to immobilized nucleic acids as well as for the colorimet-
ric detection of hybridized DNA sequences.
Fluorescence microscopy
For the fluorescence microscopy analysis cells were
grown in chamber slides and infected with FAdV-9,
rFDTR2-EGFP, and rFDTR2-EGFPinv at a multiplicity of
infection (m.o.i.) of 1. The cells were washed twice with
PBS and covered with a coverslip. EGFP expression in
infected cells was observed by an Olympus Provis AX-70
microscope equipped with FITC optics.
Immunoprecipitation
CH-SAH cells were grown in 60-mm dishes, infected
with FAdV-9 and rFDTR2-EGFPinv at an m.o.i. of 5. The
cells were starved for 1 h in a methionine-deficient me-
dium for 1 h before labeling. At various times p.i. the cells
were labeled with 50 mCi/ml of Easy Tag Express
35S]methionine (NEN) for 2 h. After labeling, the cells
ere washed twice with cold PBS and disrupted in 500
ml of lysis buffer (PBS containing 0.5% Triton X-100 and
0.1 mM PMSF). The lysate was cleared by centrifugation
at 14,000 rpm in an Eppendorf 5415C microcentrifuge for
20 min at 4°C and the supernatant was transferred to a
clean tube. Fifty-microliter aliquots of the lysate was
used for immunoprecipitations. In the preclearing step to
remove nonspecifically bound material the lysate was
mixed with 30 ml of Pansorbin cells (Calbiochem), incu-
bated for 1 h on ice, and centrifuged at 14,000 rpm in an
Eppendorf 5415C microcentrifuge for 1 min at 4°C. The
supernatant was transferred into a fresh tube and 2 ml of
Living Colors (JL-8) monoclonal antibody (Clontech) was
added and kept on ice for 2 h, while mixing regularly. In
the precipitation step, 30 ml of Pansorbin cells were
added and kept on ice, mixing regularly. Immune com-
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205TR-2 IS NOT REQUIRED FOR FAdV REPLICATIONplexes were pelleted by centrifugation at 14,000 rpm in
an Eppendorf 5415C microcentrifuge for 1 min at 4°C.
The immunoprecipitates were solubilized in SDS sample
buffer, subjected to electrophoresis in 10% SDS–polyac-
rylamide gels, and analyzed by fluorography.
One-step growth curve
CH-SAH cells were grown in 35-mm tissue culture plates
and infected with FAdV-9 and rFDTR2-EGFPinv at an m.o.i.
of 5. At various times p.i. the medium was removed and
frozen at 270°C, the cells were washed 3 times with PBS,
ml of fresh medium was added to each plate, and the
lates were frozen at 270°C. The cells were freeze-thawed
times before titrations. Plaque assays were carried out for
oth intracellular and extracellular virus as described else-
here (Alexander et al., 1998).
T-PCR
Total RNA from CH-SAH cells infected with FAdV-9
nd rFDTR2-EGFPinv at an m.o.i. of 5 was extracted at
arious times p.i. by Trizol (Life Technologies). The
otal RNA was first treated with DNaseI (Life Technol-
gies) to remove any traces of viral DNA. First-strand
DNA synthesis was carried out in a total reaction
olume of 20 ml. For the first-strand cDNA synthesis 2
mg of total RNA was mixed with 100 ng of random
rimers (Life Technologies), heated at 70°C, and then
hilled on ice. After addition of 1 ml of 10 mM dNTP
ix, 4 ml of 53 first-strand buffer [250 mM Tris–HCl
pH 8.3), 375 mM KCl, 15 mM MgCl2], and 2 ml of 0.1
M DTT, the reactions were incubated for 10 min at
5°C. Two-hundred units of SuperScript II RNaseH2
reverse transcriptase (Life Technologies) was added,
mixed gently, and incubated at 45°C for 45 min. After
heat inactivation (70°C for 15 min) the reactions were
treated with 2 U of E. coli RNaseH (Life Technologies)
at 37°C for 20 min to remove the RNA. Two-microliter
aliquots of the first-strand reactions were taken for
PCR amplification in a total reaction volume of 50 ml.
Reactions without reverse transcriptase were the neg-
ative control used to ascertain that no residual viral
DNA was present. Two sets of primers were used for
PCR amplification to evaluate EGFP mRNA expression:
TR-F2 (59-GTTACGCTCCACCCCGAATCCAG-39) and
TR-R2 (59-GGGACAAGGTTTACACGGACGAGA-39),
lanking the EGFP ORF. The results of RT-PCR analysis
btained by using internal EGFP primers, 3EGFP (59-
AGCAGAAGAACGGCATCAAGGTG-39), and EGFP-R
59-CACGAACTCCAGCAGGACCATG-39) are not
hown.
9 and 39 rapid amplification of cDNA ends (59-RACE)
59- and 39-RACE kits (Life Technologies) were used
ccording to the manufacturer’s recommendations. Total
NA was extracted from cells infected with rFDTR2- CGFPinv at 8 and 24 h.p.i., pooled, and reverse tran-
cribed as described above. 59-RACE was done with two
GFP specific primers: 5EGFP (59GGGTCTTGTAGTTGC-
GTCGTCCT39) and nested EGFP-E (59TTGAAT-
CATCGCCCTCGCCCTCGCCG39). 39-RACE was also
arried out with two EGFP specific primers: 3EGFP
59AAGCAGAAGAACGGCATCAAGGTG39) and nested
GFP-C (59CATGGTCCTGCTGGAGTTCGTG39). The 59-
and 39-RACE amplification products were gel purified
and cloned in pUC19. The nucleotide sequence of cloned
cDNA was determined as described below.
Sequencing and nucleotide sequence analysis
All sequencing reactions were carried out with an
Applied Biosystems 377 automated sequencer located at
the University of Guelph Molecular Supercentre. Se-
quence analysis, plasmid map drawing, and oligonucle-
otide design were done by the Vector NTI 5.0 software
package (Informax Inc.).
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